NTGN Neon Therapeutics Inc.

+0.03  (+1%)
Previous Close 4.62
Open 4.66
Price To Book 1.6
Market Cap 131,740,750
Shares 28,331,344
Volume 14,389
Short Ratio
Av. Daily Volume 140,495

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1b data due 3Q 2020.
NEO-PV-01 + Keytruda - NT-002
Non-small Cell Lung Cancer (NSCLC)
Phase 1b top-line data released July 15, 2019. NSCLC - median PFS 5.6 months; melanoma - median PFS not yet reached.
NEO-PV-01 + nivolumab NT-001
Melanoma, Lung Cancer or Bladder Cancer
Phase 1b data due 2H 2020.
NEO-PV-01 and nivolumab - NT-003

Latest News

  1. Neon Therapeutics Shares Higher After Positive Cancer Vaccine Study
  2. Neon Therapeutics’ Personal Neoantigen Vaccine Study Demonstrates Prolonged Progression-Free Survival in Advanced or Metastatic Melanoma, Non-Small Cell Lung and Bladder Cancers
  3. Can We See Significant Institutional Ownership On The Neon Therapeutics, Inc. (NASDAQ:NTGN) Share Register?
  4. Neon Therapeutics to Present at Jefferies 2019 Healthcare Conference
  5. Neon Therapeutics Reports First Quarter 2019 Financial Results and Provides Clinical Update
  6. 3 Small Drug Stocks Poised to Beat Q1 Earnings Estimates
  7. Alibaba (BABA) Gears Up for Q4 Earnings: What's in Store?
  8. Neon Therapeutics to Present at Bank of America Merrill Lynch 2019 Health Care Conference
  9. Will Life Sciences Sales Boost Bio-Rad's (BIO) Q1 Earnings?
  10. What's in Store for Booking Holdings' (BKNG) Q1 Earnings?
  11. What's in the Offing for TripAdvisor's (TRIP) Q1 Earnings?
  12. Can Epidolex Drive GW Pharmaceuticals' (GWPH) Q2 Earnings?
  13. Neon Therapeutics Announces Completion of Enrollment in Phase 1b NT-002 Clinical Trial of NEO-PV-01 in Metastatic Non-Small Cell Lung Cancer
  14. Neon Therapeutics Presents Updated Data from Ongoing Phase 1b NT-001 Clinical Trial of Personal Neoantigen Vaccine NEO-PV-01 at AACR 2019 Annual Meeting
  15. Neon Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
  16. Neon Therapeutics to Present at Cowen and Company 39th Annual Health Care Conference
  17. Neon Therapeutics to Present at the American Association for Cancer Research Annual Meeting
  18. Neon Therapeutics to Present at 8th Annual Leerink Partners Global Healthcare Conference
  19. These 4 Biotech Stocks Are Leading The Industry